美国 · SEC FORM 4
PRECIGEN, INC.
PGEN · Nasdaq · CIK 0001356090 · Healthcare · Biotechnology
内部人信号
1 qualifying P purchase group
当前 180 天评分窗口
42 同一窗口内观察到的 Form 4 交易行
16 sales · 25 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度与集中度
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-08-21 · AGEE NANCY H.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 47,547,517
- 上期报告
- 42,278,237
- 日均成交量
- 6,444,570
- 回补天数
- 7.4
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-21 | AGEE NANCY H | 买入 (P) | Common Stock | 3,411 | USD 7.23 | USD 24,662 | SEC 申报 ↗ |
| 2025-09-29 | Tennant Phil | 买入 (P) | Common Stock | 6,000 | USD 3.58 | USD 21,480 | SEC 申报 ↗ |
| 2025-09-26 | Shah Rutul R | 买入 (P) | Common Stock | 2,000 | USD 3.40 | USD 6,800 | SEC 申报 ↗ |
| 2025-09-26 | Thomasian Harry Jr. | 买入 (P) | Common Stock | 2,932 | USD 3.42 | USD 10,027 | SEC 申报 ↗ |
| 2025-09-25 | Thomasian Harry Jr. | 买入 (P) | Common Stock | 8,284 | USD 3.62 | USD 29,988 | SEC 申报 ↗ |
| 2025-09-04 | AGEE NANCY H | 买入 (P) | Common Stock | 15,000 | USD 4.60 | USD 69,000 | SEC 申报 ↗ |
| 2025-08-28 | AGEE NANCY H | 买入 (P) | Common Stock | 10,645 | USD 4.65 | USD 49,499 | SEC 申报 ↗ |
| 2025-08-19 | AGEE NANCY H | 买入 (P) | Common Stock | 15,360 | USD 3.20 | USD 49,152 | SEC 申报 ↗ |
| 2024-08-09 | Perez Jeffrey Thomas | 买入 (P) | Common Stock | 58,823 | USD 0.85 | USD 50,000 | SEC 申报 ↗ |
| 2024-08-09 | KIRK RANDAL J | 买入 (P) | Common Stock | 23,529,411 | USD 0.85 | USD 19,999,999 | SEC 申报 ↗ |
| 2023-12-28 | KIRK RANDAL J | 买入 (P) | Common Stock | 96,686 | USD 1.41 | USD 136,327 | SEC 申报 ↗ |
| 2023-09-22 | MITCHELL DEAN J | 买入 (P) | Common Stock | 25,000 | USD 1.41 | USD 35,250 | SEC 申报 ↗ |
| 2023-08-16 | KIRK RANDAL J | 买入 (P) | Common Stock | 119,411 | USD 1.51 | USD 180,311 | SEC 申报 ↗ |
| 2023-08-15 | KIRK RANDAL J | 买入 (P) | Common Stock | 380,589 | USD 1.52 | USD 577,301 | SEC 申报 ↗ |
| 2023-08-14 | Hassan Fred | 买入 (P) | Common Stock | 570,345 | USD 1.75 | USD 998,104 | SEC 申报 ↗ |
Form 4 申报证据
87 transaction lines in the latest 365-day window; 579 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Thomasian Harry Jr. | 期权行权／转换 (M) | Common Stock | 53,665 | USD 2.81 | USD 150,714 | SEC 申报 ↗ |
| 2026-08-26 | KINDLER JEFFREY B | 卖出 (S) | Common Stock | 185,000 | USD 7.44 | USD 1,376,400 | SEC 申报 ↗ |
| 2026-08-25 | Tennant Phil | 卖出 (S) | Common Stock | 79,166 | USD 7.50 | USD 593,745 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Thomasian Harry Jr. | 期权行权／转换 (M) | Common Stock | 53,665 | USD 2.81 | USD 150,714 | SEC 申报 ↗ |
| 2026-08-26 | KINDLER JEFFREY B | 卖出 (S) | Common Stock | 185,000 | USD 7.44 | USD 1,376,400 | SEC 申报 ↗ |
| 2026-08-25 | Tennant Phil | 卖出 (S) | Common Stock | 79,166 | USD 7.50 | USD 593,745 | SEC 申报 ↗ |
| 2026-08-25 | Tennant Phil | 期权行权／转换 (M) | Common Stock | 79,166 | USD 1.61 | USD 127,457 | SEC 申报 ↗ |
| 2026-08-25 | Shah Rutul R | 卖出 (S) | Common Stock | 15,342 | USD 7.50 | USD 115,065 | SEC 申报 ↗ |
| 2026-08-25 | Shah Rutul R | 期权行权／转换 (M) | Common Stock | 15,342 | USD 2.33 | USD 35,747 | SEC 申报 ↗ |
| 2026-08-23 | Thomasian Harry Jr. | 期权行权／转换 (M) | Common Stock | 7,291 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-23 | Thomasian Harry Jr. | 代扣税 (F) | Common Stock | 3,577 | USD 7.20 | USD 25,754 | SEC 申报 ↗ |
| 2026-08-23 | Tennant Phil | 期权行权／转换 (M) | Common Stock | 5,208 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-23 | Tennant Phil | 代扣税 (F) | Common Stock | 2,585 | USD 7.20 | USD 18,612 | SEC 申报 ↗ |
| 2026-08-23 | Shah Rutul R | 期权行权／转换 (M) | Common Stock | 7,500 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-23 | Shah Rutul R | 代扣税 (F) | Common Stock | 3,647 | USD 7.20 | USD 26,258 | SEC 申报 ↗ |
| 2026-08-23 | Sabzevari Helen | 期权行权／转换 (M) | Common Stock | 20,833 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-23 | Sabzevari Helen | 代扣税 (F) | Common Stock | 10,184 | USD 7.20 | USD 73,325 | SEC 申报 ↗ |
| 2026-08-23 | Lehr Donald P. | 期权行权／转换 (M) | Common Stock | 5,208 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-23 | Lehr Donald P. | 代扣税 (F) | Common Stock | 2,488 | USD 7.20 | USD 17,914 | SEC 申报 ↗ |
| 2026-08-21 | Shah Rutul R | 卖出 (S) | Common Stock | 34,658 | USD 7.50 | USD 259,935 | SEC 申报 ↗ |
| 2026-08-21 | Shah Rutul R | 期权行权／转换 (M) | Common Stock | 34,658 | USD 2.33 | USD 80,753 | SEC 申报 ↗ |
| 2026-08-21 | AGEE NANCY H | 买入 (P) | Common Stock | 3,411 | USD 7.23 | USD 24,662 | SEC 申报 ↗ |
| 2026-08-06 | Shah Rutul R | 卖出 (S) | Common Stock | 32,739 | USD 6.86 | USD 224,590 | SEC 申报 ↗ |
| 2026-08-03 | Shah Rutul R | 卖出 (S) | Common Stock | 33,772 | USD 6.50 | USD 219,518 | SEC 申报 ↗ |
| 2026-08-03 | Shah Rutul R | 期权行权／转换 (M) | Common Stock | 33,772 | USD 2.33 | USD 78,689 | SEC 申报 ↗ |
| 2026-07-31 | Thomasian Harry Jr. | 卖出 (S) | Common Stock | 100,000 | USD 6.06 | USD 606,000 | SEC 申报 ↗ |
| 2026-07-01 | Thomasian Harry Jr. | 卖出 (S) | Common Stock | 171,429 | USD 5.53 | USD 948,002 | SEC 申报 ↗ |
| 2026-06-29 | Thomasian Harry Jr. | 卖出 (S) | Common Stock | 28,571 | USD 5.78 | USD 165,140 | SEC 申报 ↗ |
| 2026-06-29 | Shah Rutul R | 卖出 (S) | Common Stock | 42,924 | USD 5.85 | USD 251,105 | SEC 申报 ↗ |
| 2026-06-29 | Shah Rutul R | 期权行权／转换 (M) | Common Stock | 42,924 | USD 2.33 | USD 100,013 | SEC 申报 ↗ |
| 2026-06-29 | Sabzevari Helen | 卖出 (S) | Common Stock | 346,836 | USD 5.89 | USD 2,042,864 | SEC 申报 ↗ |
| 2026-06-29 | Sabzevari Helen | 期权行权／转换 (M) | Common Stock | 346,836 | USD 2.33 | USD 808,128 | SEC 申报 ↗ |
| 2026-05-28 | Thomasian Harry Jr. | 卖出 (S) | Common Stock | 41,884 | USD 4.36 | USD 182,614 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | PGEN |
| CIK | 0001356090 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 579 transaction lines from 2020-01-02 to 2026-09-23 65 P purchase lines · 193 S sale lines · 321 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.